Petit Cactus Study
Petit Cactus: A Carbohydrate Counting Mobile Application for Canadians With Type 1 Diabetes - A Proof-of-Concept Study
1 other identifier
interventional
73
1 country
1
Brief Summary
The goal of this trial is to test a newly developed carbohydrate counting mobile application (named Petit Cactus) with photo recognition, for people with type 1 diabetes. To evaluate Petit Cactus, our objectives are: 1. To measure the association between app engagement and changes in blood glucose management over the same period. 2. To assess the usability of the app, focusing on engagement (i.e., frequency of meal logs) over 3 months and user satisfaction. 3. To validate the nutritional data obtained from the app's photo recognition algorithm by comparing it with a validated nutrient intake method (in this case, a web-based 24h recall). Participants will submit their Ambulatory Glucose Profile (i.e., CGM data) at the beginning and at the end of 3 months, download the app to use for carbohydrate counting for the 3-month duration, complete a usability questionnaire at the end of 3 months, and complete an end-of-study interview to report on their satisfaction with the app.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2025
CompletedFirst Submitted
Initial submission to the registry
September 22, 2025
CompletedFirst Posted
Study publicly available on registry
February 2, 2026
CompletedFebruary 2, 2026
January 1, 2026
6 months
September 22, 2025
January 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Time-in-Range
Percentage of the time that glucose levels were within the recommended range (3.9 mmol/L and 10 mmol/L)
At baseline and 3 months
Estimated A1c
Estimated glucose levels i.e., glucose management indicator (GMI)
At baseline and at 3 months
Engagement
the frequency of meal logs in the app
Throughout the 3 months
System Usability System Scale
System usability system (SUS) scale / 10 items) to assess how usable a system (the app) is, the higher the score (out of 100) the higher the usability.
At 3 months
Usability perception and experiences themes
Thematic analysis of semi-structured interviews using an interview guide entered around the 10 items of the system usability scale
At 3 months
Secondary Outcomes (1)
Petit Cactus' nutrient analysis validation
Five random days from baseline until the end of the 3-month trial
Study Arms (1)
Petit Cactus
EXPERIMENTALAccess to "Petit Cactus" carbohydrate counting app to assist with meal logs for 3 months
Interventions
Access to the mobile application named Petit Cactus for 3 months to assist with carbohydrate counting in the context of type 1 diabetes using the following features: 1) Identify and log food items and estimate quantities through both photo recognition and manual selection from canadian food databases, 2) Automatically calculate and suggest the bolus insulin dose needed for a meal, based on the insulin-to-carbohydrate ratios entered in the settings and previously determined by the endocrinologist and healthcare team. 3) Track meals and different logged events (physical activity, stress levels, menstrual cycle...) and their impact on blood glucose levels.
Eligibility Criteria
You may qualify if:
- Diagnosed with T1D for at least 1 year on basal-bolus insulin regimen
- Uses a Continuous Glucose Monitoring (CGM) system
- Aged 14 years or older; 4. Residing in Canada
- Able to speak/understand French or English
- Uses carbohydrate counting as part of treatment regimen i.e., knows their insulin-to-carb ratio and correction factors.
You may not qualify if:
- \- Unable to use a smartphone with internet access
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McGill Universitylead
- Laval Universitycollaborator
Study Sites (1)
McGill University
Montreal, Quebec, H9X 3V9, Canada
Related Publications (6)
Housni A, Katz A, Bergeron LJ, Simard A, Finkel A, Roy-Fleming A, Nakhla M, Brazeau AS. Bridging the Gap in Carbohydrate Counting With a Mobile App: Needs Assessment Survey. J Med Internet Res. 2025 Mar 28;27:e63278. doi: 10.2196/63278.
PMID: 40153793RESULTLaramee C, Lemieux S, Robitaille J, Lamarche B. Comparing the Usability of the Web-Based 24-h Dietary Recall R24W and ASA24-Canada-2018 among French-Speaking Adults from Quebec. Nutrients. 2022 Oct 28;14(21):4543. doi: 10.3390/nu14214543.
PMID: 36364803RESULTFu S, Li L, Deng S, Zan L, Liu Z. Effectiveness of advanced carbohydrate counting in type 1 diabetes mellitus: a systematic review and meta-analysis. Sci Rep. 2016 Nov 14;6:37067. doi: 10.1038/srep37067.
PMID: 27841330RESULTFortin A, Rabasa-Lhoret R, Roy-Fleming A, Desjardins K, Brazeau AS, Ladouceur M, Gingras V. Practices, perceptions and expectations for carbohydrate counting in patients with type 1 diabetes - Results from an online survey. Diabetes Res Clin Pract. 2017 Apr;126:214-221. doi: 10.1016/j.diabres.2017.02.022. Epub 2017 Feb 22.
PMID: 28273644RESULTZiegler R, Rees C, Jacobs N, Parkin CG, Lyden MR, Petersen B, Wagner RS. Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy: results of the Bolus Advisor Benefit Evaluation (BABE) study. Pediatr Diabetes. 2016 Aug;17(5):311-8. doi: 10.1111/pedi.12290. Epub 2015 Jun 15.
PMID: 26073672RESULTTascini G, Berioli MG, Cerquiglini L, Santi E, Mancini G, Rogari F, Toni G, Esposito S. Carbohydrate Counting in Children and Adolescents with Type 1 Diabetes. Nutrients. 2018 Jan 22;10(1):109. doi: 10.3390/nu10010109.
PMID: 29361766RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Anne-Sophie Brazeau, PhD
McGill University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 22, 2025
First Posted
February 2, 2026
Study Start
February 20, 2025
Primary Completion
August 15, 2025
Study Completion
August 30, 2025
Last Updated
February 2, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared due to ethical considerations and the lack of participant consent for data sharing beyond the current study.